Rani Therapeutics Holdings Inc (RANI) — Cash Flow-to-Debt Ratio
Latest as of March 2026:
-0.40x
Rani Therapeutics Holdings Inc (RANI) has a Cash Flow-to-Debt Ratio of -0.40x as of March 2026, meaning its operating cash flow of $-6.50 Million could theoretically repay 0% of its total liabilities ($16.34 Million) in one year. See RANI FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
CF-to-Debt Ratio
-0.40x
Operating CF / Total Liabilities
Operating Cash Flow
$-6.50 Million
USD
Total Liabilities
$16.34 Million
USD
Data as of
Mar 2026
Most recent filing
Rani Therapeutics Holdings Inc Cash Flow-to-Debt Ratio (2019–2025)
Historical debt coverage capacity for Rani Therapeutics Holdings Inc across 7 annual periods. For the full cash flow conversion analysis, see Rani Therapeutics Holdings Inc cash conversion from operations.
Annual Cash Flow-to-Debt Ratio for Rani Therapeutics Holdings Inc (2019–2025)
Year-by-year debt coverage analysis for Rani Therapeutics Holdings Inc.
| Year | CF-to-Debt Ratio | Operating CF (USD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | -1.09x | $-18.71 Million | $17.11 Million | ▼ -2.1% |
| 2024 | -1.07x | $-35.50 Million | $33.14 Million | ▲ +32.1% |
| 2023 | -1.58x | $-51.24 Million | $32.47 Million | ▼ -15.4% |
| 2022 | -1.37x | $-46.52 Million | $34.02 Million | ▲ +88.8% |
| 2021 | -12.21x | $-32.24 Million | $2.64 Million | ▼ -15637.3% |
| 2020 | -0.08x | $-14.96 Million | $192.75 Million | ▲ +64.6% |
| 2019 | -0.22x | $-26.27 Million | $119.66 Million | — |
Cash Flow-to-Debt Ratio = Operating Cash Flow / Total Liabilities. Higher is better for debt service capacity.